Literature DB >> 648557

Uptake and subcellular localization of daunorubicin and adriamycin in cultured fibroblasts.

G Noel, C Peterson, A Trouet, P Tulkens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 648557     DOI： 10.1016/0014-2964(78)90206-2

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  24 in total

Review 1.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

2.  Intracellular concentrations of anti cancer drugs in leukemic cells in vitro vs in vivo.

Authors:  B Sundman-Engberg; U Tidefelt; J Liliemark; C Paul
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

3.  Comparative studies of the uptake of daunorubicin in sensitive and resistant P388 cell lines by flow cytometry and biochemical extraction procedures.

Authors:  A T McGown; T H Ward; B W Fox
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

4.  Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.

Authors:  D M Siegel; S N Giri; R M Scheinholtz; L W Schwartz
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

5.  Cellular pharmacokinetics of daunorubicin: uptake by leukaemic cells in vivo and fate.

Authors:  V Trillet; M Lakhal; J Lang; E Perrin-Fayolle; Q Timour Chah; D Fière; G Faucon
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Metabolism of daunorubicin in sensitive and resistant Ehrlich ascites tumor cells. Determination by high pressure liquid chromatography.

Authors:  D Londos-Gagliardi; R Baurain; J Robert; G Aubel-Sadron
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

7.  Cardiomyopathy in leukemia, with reference to rubidomycin cardiotoxicity.

Authors:  B Lantz; J Adolfsson; B Lagerlöf; P Reizenstein
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

8.  Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cells.

Authors:  C Paul; C Peterson; G Gahrton; D Lockner
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

9.  Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites.

Authors:  K Wassermann; E Steiness
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

10.  Uptake, metabolism, and cytotoxicity of doxorubicin in human Ewing's sarcoma and rhabdomyosarcoma cells.

Authors:  M W DeGregorio; G M Lui; B A Macher; J R Wilbur
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.